David Zidar, MD
Showing of 3 results
![](/-/media/images/physician-headshots/z/zidar-david-cardiovasc-007-700x750.jpg?mw=304&h=326&w=304&la=en&hash=A9C0C9664BECC683FB602DA69042626C)
Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients
Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018 David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...
![](/-/media/images/physician-headshots/z/zidar-david-cardiovasc-007-700x750.jpg?mw=304&h=326&w=304&la=en&hash=A9C0C9664BECC683FB602DA69042626C)
Statins Under-Prescribed in the Young with Severe Dyslipidemia
Harrington Heart & Vascular Institute Innovations | Winter 2017
![](/-/media/images/for-clinicians/articles-and-news/2021/11/chest-heart-illustration-700x750.jpg?mw=304&h=326&w=304&la=en&hash=69A680BC38C52E8930973053EC7ABFA5)
Making the Case for CT CORONARY CALCIUM SCORING
Harrington Heart & Vascular Institute Innovations | Spring 2016
Results are loading...